[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336672-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336672-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","discovery-and-validation-of-methylation-signatures-in-circulating-cell-free-dna-for-the-detection-of-colorectal-cancer-article","Discovery and Validation of Methylation Signatures in Circulating Cell-Free DNA for the Detection of Colorectal Cancer - Article","","Assessing cfDNA methylation performance for detecting colorectal cancer (CRC). Five tumor tissue, 20 peripheral blood leucocyte, and 169 cfDNA samples were collected for whole-genome bisulfite sequencing (WGBS). Differentially methylated regions (DMRs) were identified through bioinformatic analyses and further characterized functionally. Quantitative methylation-specific PCR (qMSP) validated DMR methylation in tissues and leucocytes, while CRC patient and healthy control cfDNA evaluated diagnostic performance. WGBS showed reduced CpG methylation in CRC tumors and identified 132 cfDNA DMRs, with three-DMR combination achieving AUC 0.763, sensitivity 64.21%, and specificity 78.38%, supporting non-invasive biomarker potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/discovery-and-validation-of-methylation-signatures-in-circulating-cell-free-dna-for-the-detection-of-colorectal-cancer-article/336672/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/discovery-and-validation-of-methylation-signatures-in-circulating-cell-free-dna-for-the-detection-of-colorectal-cancer-article/336672.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What samples were used in the study to evaluate cfDNA methylation for CRC detection?","Question",{"text":63,"@type":64},"The study collected five tumor tissue samples, 20 peripheral blood leucocyte samples, and 169 cfDNA samples for WGBS and downstream analyses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were methylation differences identified and validated?",{"text":68,"@type":64},"Bioinformatic analysis of WGBS data identified differentially methylated regions (DMRs), and quantitative methylation-specific PCR (qMSP) validated DMR methylation levels in tissues and leucocytes.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic performance did the combined DMR panel achieve?",{"text":72,"@type":64},"In a cohort of 95 CRC patients and 74 healthy controls, a combination of three DMRs (DAB1, PPP2R5C, and FAM19A5) achieved an AUC of 0.763, with 64.21% sensitivity and 78.38% specificity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336672,1790119062,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","biomolecules  \nArticle  \nDiscovery and Validation of Methylation Signatures in  \nCirculating Cell-Free DNA for the Detection of Colorectal Cancer  \nZhiping Long 1,†, Yu Gao 1,†, Zhen Han 1, Heli Yuan 1, Yue Yu 1, Bing Pei 1, Yanjie Jia 1, Jingyu Ye 1, Ying Shi 1, Min Zhang 1, Yashuang Zhao 1, Di Wu 2,* and Fan Wang 1, *  \nCitation: Long, Z.; Gao, Y.; Han, Z.; Yuan, H.; Yu, Y.; Pei, B.; Jia, Y.; Ye, J.; Shi, Y.; Zhang, M.; et al. Discovery and Validation of Methylation Signatures in Circulating Cell-Free DNA for the Detection of Colorectal Cancer. Biomolecules 2024, 14, 996 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biom14080996  \nAcademic Editors: Yves Ménézo, Eleonora Loi, Ana Florencia Vega Benedetti and Patrizia Zavattari  \nReceived: 18 May 2024  \nRevised: 25 July 2024  \nAccepted: 9 August 2024  \nPublished: 13 August 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150028, China; [202101040@hrbmu.edu.cn](202101040@hrbmu.edu.cn) (Z.L.); [gaoyu@hrbmu.edu.cn](gaoyu@hrbmu.edu.cn) (Y.G.); [2020020160@hrbmu.edu.cn](2020020160@hrbmu.edu.cn) (Z.H.); [2022020094@hrbmu.edu.cn](2022020094@hrbmu.edu.cn) (H.Y.); [2020020138@hrbmu.edu.cn](2020020138@hrbmu.edu.cn) (Y.Y.); [202301087@hrbmu.edu.cn](202301087@hrbmu.edu.cn) (B.P.); [2022020085@hrbmu.edu.cn](2022020085@hrbmu.edu.cn) (Y.J.); [2021020292@hrbmu.edu.cn](2021020292@hrbmu.edu.cn) (J.Y.); [2023020198@hrbmu.edu.cn](2023020198@hrbmu.edu.cn) (Y.S.); [2022020101@hrbmu.edu.cn](2022020101@hrbmu.edu.cn) (M.Z.); [zhao_yashuang@263.net](zhao_yashuang@263.net) (Y.Z.)  \n2 Department of Colorectal Surgery, Tumor Hospital of Harbin Medical University, Harbin Medical University, Harbin 150081, China  \n* [Correspondence: wudidididi@163.com](Correspondence: wudidididi@163.com) (D.W.); [yifan.701@163.com](yifan.701@163.com) (F.W.); Tel.: +86-(0)451-87502960 (F.W.); Fax: +86-(0)451-87502885 (F.W.)  \n† These authors contributed equally to this work.  \nAbstract: This study was conducted with the primary objective of assessing the performance of cfDNA methylation in the detection of colorectal cancer (CRC) . Five tumor tissue, 20 peripheral blood leucocyte, and 169 cfDNA samples were collected for whole-genome bisulfite sequencing (WGBS) analysis. Bioinformatic analysis was conducted to identify differentially methylated regions (DMRs) and their functional characteristics. Quantitative methylation-specific PCR (qMSP) was used to validate the methylation levels of DMRs in the tissues and leucocytes. cfDNA samples from CRC patients and healthy controls were used to evaluate the performance of the DMR analysis. WGBS analysis revealed a decrease in DNA methylation levels in the CpG context in CRC tumor tissues compared with adjacent normal tissues. A total of 132 DMRs in cfDNA were identified as potential markers for diagnosing CRC. In a cohort of 95 CRC patients and 74 healthy controls, a combination of the three DMRs (DAB1, PPP2R5C, and FAM19A5) yielded an AUC of 0.763, achieving 64.21% sensitivity and 78.38% specificity in discriminating CRC patients from healthy controls. This study provides insights into DNA methylation patterns in CRC and identifies a set of DMRs in cfDNA with potential diagnostic value for CRC. These DMRs hold promise as biomarkers for CRC detection, offering promise for non-invasive CRC diagnosis. Further research is warranted to validate these findings in larger cohorts.  \nKeywords: colorectal cancer; methylation; WGBS; cfDNA; biomarkers  \n1. Introduction  \nColorectal cancer (CRC) is one of the deadliest cancers with a poor prognosis and increa","cbCaiu4YNaSMuHPE","https://ap.wps.com/l/cbCaiu4YNaSMuHPE","pdf",2091830,14,"English","# Abstract\n# Introduction\n## Background and need for early CRC detection\n## Limits of existing screening and biomarkers\n## Rationale for cfDNA methylation and liquid biopsy","[{\"question\":\"What samples were used in the study to evaluate cfDNA methylation for CRC detection?\",\"answer\":\"The study collected five tumor tissue samples, 20 peripheral blood leucocyte samples, and 169 cfDNA samples for WGBS and downstream analyses.\"},{\"question\":\"How were methylation differences identified and validated?\",\"answer\":\"Bioinformatic analysis of WGBS data identified differentially methylated regions (DMRs), and quantitative methylation-specific PCR (qMSP) validated DMR methylation levels in tissues and leucocytes.\"},{\"question\":\"What diagnostic performance did the combined DMR panel achieve?\",\"answer\":\"In a cohort of 95 CRC patients and 74 healthy controls, a combination of three DMRs (DAB1, PPP2R5C, and FAM19A5) achieved an AUC of 0.763, with 64.21% sensitivity and 78.38% specificity.\"}]","Discovery and Validation of Methylation Signatures in Circulating Cell-Free DNA for the Detection of Colorectal Cancer - Article | PDF",1790016122,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99395a0cd76eeba4afca49c5eb378b2c.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84d15b80bd68302d745235505c29322b.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba26ddc85a89d7d5c96635f8e0c03e62.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a53342d20feea75b7636b2d5f2b8d91.webp",980,1385]